FXS6837 for the Treatment of IgAN Patients
Clinical trial NCT07502638 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07502638
- Sponsor
- Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-31
- Primary completion
- 2027-09-12
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.